Allen Easley Cato serves as Executive at VistaGen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Allen Easley Cato has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 15, 2011 involved exercising options for 11,363 shares valued at $113.6M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 15, 2011 | VSTA | $113.6M | Conversion | 11,363 | $9999.44 | Discretionary |
Allen Easley Cato currently holds 28,497 shares of VistaGen Therapeutics, Inc. (VSTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allen Easley Cato has been a net neutral trader of VSTA stock. They have purchased $0 and sold $0 worth of shares.
Allen Easley Cato's most recent insider trade was on Dec 15, 2011, when they sold 11,363 shares at $9999.44 per share.
Get notified when new Form 4 filings are submitted